BIOMAT Database Logo BIOMAT Database Logo

Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients. 1994

A M Dickinson, and L Sviland, and P J Hamilton, and P Usher, and P Taylor, and G Jackson, and J Dunn, and S J Proctor
Department of Haematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK.

An in vitro skin explant model has been used to predict the severity of acute graft-versus-host disease (GVHD) in 34 HLA-identical bone marrow transplant recipients (correlation coefficient 0.6 p < 0.001). Supernatants from HLA-matched patient/donor mixed lymphocyte cultures (MLCs) were analysed for levels of tumour necrosis factor alpha (TNF alpha) and interferon gamma (IFN gamma). High levels of both cytokines correlated with the development of GVHD grades II or above (p < 0.05). The supernatants were also tested for induction of class II MHC antigen expression on third party skin and results correlated with clinical outcome in 17 of 22 cases (77%) (correlation coefficient 0.65, p < 0.001). The results suggest that measurement of both TNF alpha and IFN gamma in HLA-matched MLC supernatants is of predictive value and that the skin explant model is a useful model for studying the aetiology of GVHD in humans.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

A M Dickinson, and L Sviland, and P J Hamilton, and P Usher, and P Taylor, and G Jackson, and J Dunn, and S J Proctor
Predicting graft-versus-host disease in allogeneic bone marrow transplant recipients.
June 1994, Transplant immunology,
A M Dickinson, and L Sviland, and P J Hamilton, and P Usher, and P Taylor, and G Jackson, and J Dunn, and S J Proctor
Cataract surgery in allogeneic bone marrow transplant recipients with graft-versus-host disease(1).
March 2002, Journal of cataract and refractive surgery,
A M Dickinson, and L Sviland, and P J Hamilton, and P Usher, and P Taylor, and G Jackson, and J Dunn, and S J Proctor
Management of graft-versus-host disease in paediatric bone marrow transplant recipients.
January 2000, Paediatric drugs,
A M Dickinson, and L Sviland, and P J Hamilton, and P Usher, and P Taylor, and G Jackson, and J Dunn, and S J Proctor
The oral manifestations of chronic graft-versus-host disease (cGVHD) in paediatric allogeneic bone marrow transplant recipients.
March 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
A M Dickinson, and L Sviland, and P J Hamilton, and P Usher, and P Taylor, and G Jackson, and J Dunn, and S J Proctor
Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
May 2003, Blood,
A M Dickinson, and L Sviland, and P J Hamilton, and P Usher, and P Taylor, and G Jackson, and J Dunn, and S J Proctor
Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
March 2001, Journal of immunology (Baltimore, Md. : 1950),
A M Dickinson, and L Sviland, and P J Hamilton, and P Usher, and P Taylor, and G Jackson, and J Dunn, and S J Proctor
Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation.
November 1996, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics,
A M Dickinson, and L Sviland, and P J Hamilton, and P Usher, and P Taylor, and G Jackson, and J Dunn, and S J Proctor
Ocular manifestations of acute graft versus host disease after allogeneic bone marrow transplant.
January 2014, Boletin de la Asociacion Medica de Puerto Rico,
A M Dickinson, and L Sviland, and P J Hamilton, and P Usher, and P Taylor, and G Jackson, and J Dunn, and S J Proctor
[Intestinal involvement of chronic graft-versus host disease after allogeneic bone marrow transplantation].
August 1988, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
A M Dickinson, and L Sviland, and P J Hamilton, and P Usher, and P Taylor, and G Jackson, and J Dunn, and S J Proctor
Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host disease.
April 2000, Blood,
Copied contents to your clipboard!